相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。COMPARATIVE ANALYSIS OF ALTERNATIVE OUTCOME MEASURES FOR USE IN LUPUS NEPHRITIS TRIALS
D. Wofsy et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
EFFICACY AND SAFETY OF ABATACEPT IN LUPUS NEPHRITIS
R. Furie et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Comparison of Alternative Primary Outcome Measures for Use in Lupus Nephritis Clinical Trials
David Wofsy et al.
ARTHRITIS AND RHEUMATISM (2013)
Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
Eduardo F. Mysler et al.
ARTHRITIS AND RHEUMATISM (2013)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Abatacept for lupus nephritis Alternative definitions of complete response support conflicting conclusions
David Wofsy et al.
ARTHRITIS AND RHEUMATISM (2012)
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
Ellen M. Ginzler et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Abatacept in the Treatment of Patients With Psoriatic Arthritis
Philip Mease et al.
ARTHRITIS AND RHEUMATISM (2011)
The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial
J. T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
R. Westhovens et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
T cells and B cells in lupus nephritis
Mary H. Foster
SEMINARS IN NEPHROLOGY (2007)
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial
Joel M. Kremer et al.
ANNALS OF INTERNAL MEDICINE (2006)
The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
MH Liang et al.
ARTHRITIS AND RHEUMATISM (2006)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition
MC Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
DA Isenberg et al.
RHEUMATOLOGY (2005)
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
TM Chan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition
L Schiffer et al.
JOURNAL OF IMMUNOLOGY (2003)
Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2002)
Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide
DI Daikh et al.
JOURNAL OF IMMUNOLOGY (2001)
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
TM Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)